Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway

Fig. 1

ERp29 was downregulated in gastric carcinoma and inversely correlated with prognosis. (a) Representative images of IHC staining of GC tissues and adjacent normal tissues (40 × magnification; scale bar: 50 μm; 200 × magnification; scale bar: 20 μm). (b) Western blot analysis of ERp29 expression in 8 pairs of gastric tumor (T) and adjacent non-tumorous mucosa (N). (c) ERp29 mRNA expression level in the eight pairs of gastric tumor (T) and adjacent normal mucosa (N). *P < 0.05. (d) Representative HE and ERp29 immunohistochemical staining of different clinical stages of gastric cancers (100 × magnification; scale bar: 50 μm). (E) Kaplan-Meier survival analysis showing that downregulation of ERp29 in GC was associated with the patients’ poorer overall survival

Back to article page